Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to pr...

Por Turcotte, Eric, Wiens, Linda W, Grierson, John R, Peterson, Lanell M, Wener, Mark H, Vesselle, Hubert
Publicado em 2007

Kinetic Analysis of (18)F-Fluoride PET Images of Breast Cancer Bone Metastases

Por Doot, Robert K., Muzi, Mark, Peterson, Lanell M., Schubert, Erin K., Gralow, Julie R., Specht, Jennifer M., Mankoff, David A.
Publicado em 2010

Factors influencing the uptake of (18)F-Fluoroestradiol (FES) in patients with estrogen receptor positive (ER+) breast cancer

Por Peterson, Lanell M, Kurland, Brenda F, Link, Jeanne M, Schubert, Erin K, Stekhova, Svetlana, Linden, Hannah M, Mankoff, David A
Publicado em 2011

Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer

Por Rajendran, Joseph G., Schwartz, David L., O’Sullivan, Janet, Peterson, Lanell M., Ng, Patrick, Scharnhorst, Jeffrey, Grierson, John R., Krohn, Kenneth A.
Publicado no Clin Cancer Res (2006)

Dynamic and Static Approaches to Quantifying (18)F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF

Por Doot, Robert K., Dunnwald, Lisa K., Schubert, Erin K., Muzi, Mark, Peterson, Lanell M., Kinahan, Paul E., Kurland, Brenda F., Mankoff, David A.
Publicado em 2007

Multicenter clinical trials using (18)F-FDG PET to measure early oncology therapy response: Effects of injection-to-acquisition time variability on required sample size

Por Kurland, Brenda F, Muzi, Mark, Peterson, Lanell M, Doot, Robert K, Wangerin, Kristen A, Mankoff, David A, Linden, Hannah M, Kinahan, Paul E
Publicado no J Nucl Med (2015)

Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer: (18)F-Fluoroestradiol PET Imaging Shows Return of ER Expression

Por Currin, Erin, Peterson, Lanell M., Schubert, Erin K., Link, Jeanne M., Krohn, Kenneth A., Livingston, Robert B., Mankoff, David A., Linden, Hannah M.
Publicado no J Natl Compr Canc Netw (2016)

Effect of (18)F-FDG Uptake Time on Lesion Detectability in PET Imaging of Early-Stage Breast Cancer

Por Wangerin, Kristen A., Muzi, Mark, Peterson, Lanell M., Linden, Hannah M., Novakova, Alena, O'Sullivan, Finbarr, Kurland, Brenda F., Mankoff, David A., Kinahan, Paul E.
Publicado no Tomography (2015)

Between-Patient and Within-Patient (Site-to-Site) Variability in Estrogen Receptor Binding, Measured In Vivo by (18)F-Fluoroestradiol PET

Por Kurland, Brenda F., Peterson, Lanell M., Lee, Jean H., Linden, Hannah M., Schubert, Erin K., Dunnwald, Lisa K., Link, Jeanne M., Krohn, Kenneth A., Mankoff, David A.
Publicado em 2011

Estrogen receptor binding (FES PET) and glycolytic activity (FDG PET) predict progression-free survival on endocrine therapy in patients with ER+ breast cancer

Por Kurland, Brenda F., Peterson, Lanell M., Lee, Jean H., Schubert, Erin K., Currin, Erin R., Link, Jeanne M., Krohn, Kenneth A., Mankoff, David A., Linden, Hannah M.
Publicado no Clin Cancer Res (2016)

[F-18]-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients using Image-derived Blood Surrogate Tissue Reference Regions

Por Muzi, Mark, Peterson, Lanell M., O’Sullivan, Janet N., Fink, James R., Rajendran, Joseph G., McLaughlin, Lena J., Muzi, John P., Mankoff, David A., Krohn, Kenneth A.
Publicado no J Nucl Med (2015)

Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients

Por Kurland, Brenda F, Gadi, Vijayakrishna K, Specht, Jennifer M, Allison, Kimberly H, Livingston, Robert B, Rodler, Eve T, Peterson, Lanell M, Schubert, Erin K, Chai, Xiaoyu, Mankoff, David A, Linden, Hannah M
Publicado em 2012

A Phase 2 Study of 16α-[(18)F]-fluoro-17β-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)

Por Peterson, Lanell M., Kurland, Brenda F., Schubert, Erin K., Link, Jeanne M., Gadi, V.K., Specht, Jennifer M., Eary, Janet F., Porter, Peggy, Shankar, Lalitha K., Mankoff, David A., Linden, Hannah M.
Publicado em 2013

Fluoroestradiol (FES) Positron Emission Tomography (PET) Reveals Differences In Pharmacodynamics Of Aromatase Inhibitors, Tamoxifen, And Fulvestrant In Patients With Metastatic Bre...

Por Linden, Hannah M., Kurland, Brenda F., Peterson, Lanell M., Schubert, Erin K., Gralow, Julie R., Specht, Jennifer M., Ellis, Georgiana K., Lawton, Thomas, Livingston, Robert B., Petra, Philip H., Link, Jeanne M., Krohn, Kenneth A., Mankoff, David A.
Publicado em 2011